This inventor holds 151 USPTO granted patents and 20 published patent applications, plus 13 CIPO patents and 9 EPO patents, primarily in RNA Interference (CPC class C12N2750-14143). Top assignees: Wyvern Pharmaceuticals Inc., Oncolytics Biotech Inc., Kinase Pharma Inc.. Active years: 1984-2026.
Inventors with similar research interests:
Location History:
- Edmonton, CA (1985 - 1995)
- Clagary, CA (2003 - 2010)
- Calgary, CA (1984 - 2024)
Company Filing History:
102 out of 103 
32 out of 65 
3 out of 3 
Years Active: 1984-2026
Areas of Expertise:
Title: The Innovative Mind of Bradley G Thompson
Introduction
Bradley G Thompson, a prolific inventor based in Calgary, Canada, has made significant contributions to the field of biotechnology. With an impressive portfolio of 62 patents, he has dedicated his career to advancing knowledge and technology, particularly in the area of ribonucleic acid (RNA) research and medical applications.
Latest Patents
Among his latest innovations are compositions aimed at regulating the production of interfering ribonucleic acids (miRNA). These compositions are designed to enhance the upregulation of specific miRNA sequences that are complementary to messenger RNA (mRNA) targets, such as those encoding for critical biomolecules like JAK and ETS2. By facilitating the degradation or inactivation of target mRNA, Thompson's inventions help to lower the bioavailability of certain biomolecules, which can provide therapeutic benefits in addressing afflictions linked to their overexpression or dysregulation.
Career Highlights
Throughout his career, Thompson has been associated with notable companies including Oncolytics Biotech Inc. and Wyvern Pharmaceuticals Inc. His work at these organizations has not only propelled advancements in medical research but has also established him as a leading figure in his field. His dedication to innovation is evident in his extensive patent portfolio, which reflects his commitment to impactful solutions in biotechnology.
Collaborations
Bradley G Thompson has collaborated with fellow professionals including Matthew C Coffey and Donald Morris. Together, they have fostered a collaborative environment that encourages innovation and drives forward-thinking research practices in the biotechnology sector.
Conclusion
In conclusion, Bradley G Thompson stands out as an influential inventor whose innovative spirit has led to the development of groundbreaking patents in biotechnology. His work continues to pave the way for future advancements that can significantly impact health and medicine. As the landscape of biotechnological research evolves, Thompson’s contributions will undoubtedly play a vital role in shaping the industry’s future.